✦ LIBER ✦

P.2.078 Quetiapine improves symptoms and is well tolerated in patients with schizophrenia switched from olanzapine

✍ Scribed by I. Larmo

Book ID: 119577068
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 283 KB
Volume: 13
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(03)92031-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of quetiapine

Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone

✍ Ilkka Larmo; André de Nayer; Elmar Windhager; Irmansyah; Bernhard Lindenbauer; H 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract A __post hoc__ analysis of the SPECTRUM trial was carried out to evaluate whether the improvements in efficacy and tolerability gained on switching to quetiapine occurred consistently for patients previously treated with either: haloperidol (__n__ = 43); olanzapine (__n__ = 66); or risp

P.2.145 Olanzapine in adolescent and you

P.2.145 Olanzapine in adolescent and young adult patients with schizophrenia: Does subjective well-being improve?

✍ R.W. Dittmann; U. Hagenah; J. Junghanß; J. Linde; A. Maestele; C. Mehler-Wex; E. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 94 KB

P03-141 Switching from antipsychotic to

P03-141 Switching from antipsychotic to quetiapine XR treatment in patients with schizophrenia and high or low depression symptoms

✍ Ganesan, S.; Eggens, I.; Huizar, K.; Meulien, D. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 French ⚖ 45 KB

Switching from fluphenazine to quetiapin

Switching from fluphenazine to quetiapine ameliorates extrapyramidal symptoms and neuroendocrine side effects in patients with schizophrenia

✍ P.J. Weiden; P. Ashworth 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 284 KB

P-2-86 Fluvoxamine reduces somatic sympt

P-2-86 Fluvoxamine reduces somatic symptoms and is well tolerated in elderly depressed patients: Results from the oldest reported population treated with a selective serotonin reuptake inhibitor

✍ E. Jaquenoud; Barbara Hochstrasser; Martin Kat 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 267 KB

P.4.041 Donepezil is a well-tolerated lo

P.4.041 Donepezil is a well-tolerated long-term treatment for patients with mild to moderate Alzheimer's disease: Results from a patient cohort who completed a one-year placebo-controlled study and participated in a two-year follow-up study

✍ B. Winblad; K. Engedal; H. Soininen; F.R.J. Verhey; G. Waldemar; A. Wimo; A.-L. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 286 KB